Clinical Trial Update: A Trial Assessing Post-Operative Use of ProSpare, a Rectal Obturator in Prostate Cancer Radiotherapy [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating Post-Operative use of ProSpare, a rectal obturator, in prostate cancer radiotherapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• ProSpare

Snippet

Sponsor: Royal Marsden NHS Foundation Trust | Conditions: Cancer | Phase 2 | Status: UNKNOWN